Neurogene (NGNE) PT Raised to $55 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts NGNE Hot Sheet
Price: $35.63 --0%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 7
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 7
Join SI Premium – FREE
H.C. Wainwright analyst Mitchel Kapoor raised the price target on Neurogene (NASDAQ: NGNE) to $55.00 (from $45.00) while maintaining a Buy rating.
You May Also Be Interested In
- Neurogene (NGNE) PT Lowered to $65 at H.C. Wainwright
- WeRide Inc (WRD) PT Lowered to $10.70 at BofA Securities
- Wedbush Downgrades Globant S.A. (GLOB) to Neutral on balanced risk/reward
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
